🇪🇺 Adbry in European Union

EMA authorised Adbry on 16 July 2021

Marketing authorisation

EMA — authorised 16 July 2021

  • Marketing authorisation holder: LEO PHARMA A/S
  • Status: approved

Adbry in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Adbry approved in European Union?

Yes. EMA authorised it on 16 July 2021.

Who is the marketing authorisation holder for Adbry in European Union?

LEO PHARMA A/S holds the EU marketing authorisation.